[LCID Study Number: 20193013]

A Randomized Multi-Center Phase III Study of Individualized Stereotactic Body Radiation Therapy (SBRT) versus Trans-Arterial Chemoembolization (TACE) as a Bridge to Transplant in Hepatocellular Carcinoma

The purpose of this study is to compare the duration of disease control in treated lesions when utilizing Stereotactic Body Radiation Therapy (SBRT) versus Trans-Arterial Chemoembolization (TACE) as a bridging strategy for patients with Hepatocellular Carcinoma (HCC) eligible for liver transplantation.

Disease/Condition: Hepatocellular Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421